Evidence map›Paper›PMID 39311780›Full record

ReviewZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2024

Maturity-onset diabetes of the young type 3 complicated with type 5: A case report and literature review.

Lijuan Li, Liuping Gong, Ailin Zheng, Qiaoling Yang, Danlan Pu, Ying Zhang

Abstract readCase ReportsReview
In one paragraph

Review in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lijuan LiDepartment of Endocrinology, Chongqing Yubei District People's Hospital, Chongqing 401120, China. 954376440@qq.com.
Liuping GongDepartment of Endocrinology, Chongqing Yubei District People's Hospital, Chongqing 401120, China.
Ailin ZhengDepartment of Endocrinology, Chongqing Yubei District People's Hospital, Chongqing 401120, China.
Qiaoling YangDepartment of Endocrinology, Chongqing Yubei District People's Hospital, Chongqing 401120, China.
Danlan PuDepartment of Endocrinology, Chongqing Yubei District People's Hospital, Chongqing 401120, China.
Ying ZhangDepartment of Endocrinology, Chongqing Yubei District People's Hospital, Chongqing 401120, China. 38305922@qq.com.

Funding

the Endocrine System Research Fund of the Education Development Foundation of Shandong First Medical University 023002
6 · The paper itself

Abstract

This report describes a case of maturity-onset diabetes of the young (MODY) type 3 (MODY3) complicated with type 5 (MODY5), including the patient's clinical features, diagnosis, and treatment, and reviews relevant literature. Using next-generation sequencing of MODY (types 1-14) gene exons and Sanger sequencing for verification, the patient and her mother were assessed. Based on the clinical phenotype and genetic test results, the patient was diagnosed as MODY3 combined with MODY5. Treatment included insulin and linagliptin, with monitoring of blood glucose changes. Clinicians should enhance their understanding of MODY clinical phenotypes. In adolescents with diabetes who have congenital pancreatic and renal developmental defects, elevated high-density lipoprotein cholesterol, no spontaneous ketosis, insulin secretion defects, negative pancreatic autoantibodies, no significant insulin resistance, and who are not obese, gene testing should be conducted to screen for MODY. Accurate diagnosis and personalized treatment can aid in achieving glycemic control, improving quality of life, and optimizing reproductive planning.

Indexed as

Diabetes Mellitus, Type 2Blood GlucoseHumansInsulinBlood GlucoseInsulinhepatocyte nuclear factor 1αhepatocyte nuclear factor 1βmaturity-onset diabetes of the youngpancreatic developmental defectsrenal cysts

Identifiers

PMID39311780
PMCPMC11420971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.